Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Mink Therapeutics Inc
INKTCurrent price
0.75 USD
-0.01 USD (-1.32%)
Last closed
0.75 USD
Company
minktherapeutics.com
ISIN
US6036931029
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
29 658 730 USD
Yield for 12 month
-17.58 %
1Y
3Y
5Y
10Y
15Y
INKT
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company has a collaboration with autonomous therapeutics, inc. to develop novel therapies targeting metastatic tumors. The company was formerly known as AgenTus Therapeutics, Inc. The company was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc. Address: 149 Fifth Avenue, New York, NY, United States, 10010
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+2 704 743 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-204 617 USD
Last Year
-28 244 535 000 USD
Current Quarter
-45 100 USD
Last Quarter
-53 831 USD
Key Figures INKT
1 year
3 years
5 years
10 years
EBITDA
-17 249 290 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-97.25 %
PEG Ratio
–
Return On Equity TTM
-1238.98 %
Wall Street Target Price
8 USD
Revenue TTM
–
Book Value
-0.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.48 USD
Diluted Eps TTM
-0.48 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics INKT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History INKT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation INKT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.6715
Price Book MRQ
10.0516
Financials INKT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators INKT
For 52 weeks
0.57 USD
1.9 USD
50 Day MA
0.74 USD
Shares Short Prior Month
48 631
200 Day MA
0.88 USD
Short Ratio
1.34
Shares Short
65 342
Short Percent
0.44 %
BeatStart